Clinical Trials@2x
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • The big interview: Cisco UK and Ireland CEO David Meads
    • Covid-19 to shake up site selection decisions
    • Covid-19 forces a rethink of global supply chains

    Most Recent

    The big interview: Cisco UK and Ireland CEO David Meads

    26 May 2020
  • Investment

    Most Read

    Most Recent

  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • HiFiBiO Therapeutics concludes first cohort of Covid-19 antibody study
    • Novartis’ iptacopan reduces proteinuria in rare renal disease trial 
    • Sanofi and Regeneron report eosinophilic esophagiti trial data

    Most Recent

    Clinical Trials

    HiFiBiO Therapeutics concludes first cohort of Covid-19 antibody study

    27 Oct 2020
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Tech

    Most Read

    • Motor Oil Group CIO Nick Giannakakis interview: On digital transformation, Covid, and edge computing
    • Blurred lines: The challenges of taking down ransomware gangs

    Most Recent

    Motor Oil Group CIO Nick Giannakakis interview: On digital transformation, Covid, and edge computing

    23 Jun 2020
  • Companies

    Sections

    • Company A-Z
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • SynapCon
    • Ika-Werke
    • Cellular Technology Limited

    Most Recent

    Clinical Trials

    SynapCon

    16 Oct 2020
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Kyn Therapeutics and Merck begin Phase Ib/I trials of ARY-007

Kyn Therapeutics and Merck begin Phase Ib/I trials of ARY-007

Kyn Therapeutics in collaboration with Merck has commenced two clinical trials of EP4 receptor antagonist ARY-007.

20th December 2018

Latest News

Clinical Trials

Prilenia begins patient enrolment in HD drug trial in US

28 Oct 2020
Clinical Trials

Olatec Therapeutics initiates enrolment in oral drug trial for Covid-19

28 Oct 2020
Clinical Trials

HiFiBiO Therapeutics concludes first cohort of Covid-19 antibody study

27 Oct 2020
Clinical Trials

Novartis’ iptacopan reduces proteinuria in rare renal disease trial 

27 Oct 2020

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
Clinical Trials

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2020 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more